Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. Aug 1, 1992; 176(2): 313–325.
PMCID: PMC2119312

Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm

Abstract

Trypanosoma cruzi enters host cells via formation of an acidic vacuole which is subsequently disrupted, allowing the parasite access to the cytoplasm. We show that in an acid environment, release of the parasite surface neuraminidase is enhanced, and this release is likely mediated by a phosphatidylinositol-specific phospholipase C (PIPLC), since antibodies to a carbohydrate epitope (CRD) revealed in glycosylphosphatidylinositol (GPI)-anchored proteins after PIPLC cleavage remove the great majority of the soluble neuraminidase activity from culture supernatants. The neuraminidase is active at acidic pH, and is capable of desialylating known vacuolar constituents, i.e., lysosomal membrane glycoproteins. Parasite escape into the cytoplasm is significantly facilitated in terminal sialylation- defective mutant Lec 2 cells, and enzymatically desialylated membranes are more susceptible to lysis by a parasite hemolysin previously implicated in vacuole membrane rupture. These findings provide evidence that terminal sialylation on carbohydrate moieties contributes to maintaining lysosomal membrane integrity, and indicate a role for a protozoan-derived neuraminidase in facilitating parasite entry into host cells. These observations raise the possibility that other microbial neuraminidases may serve a similar function in acidic intracellular compartments.

Full Text

The Full Text of this article is available as a PDF (3.5M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Nogueira N, Cohn Z. Trypanosoma cruzi: mechanism of entry and intracellular fate in mammalian cells. J Exp Med. 1976 Jun 1;143(6):1402–1420. [PMC free article] [PubMed]
  • Kress Y, Tanowitz H, Bloom B, Wittner M. Trypanosoma cruzi: infection of normal and activated mouse macrophages. Exp Parasitol. 1977 Apr;41(2):385–396. [PubMed]
  • Meirelles MN, de Araujo-Jorge TC, Miranda CF, de Souza W, Barbosa HS. Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro. Eur J Cell Biol. 1986 Aug;41(2):198–206. [PubMed]
  • Ley V, Andrews NW, Robbins ES, Nussenzweig V. Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells. J Exp Med. 1988 Aug 1;168(2):649–659. [PMC free article] [PubMed]
  • Ley V, Robbins ES, Nussenzweig V, Andrews NW. The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J Exp Med. 1990 Feb 1;171(2):401–413. [PMC free article] [PubMed]
  • Andrews NW, Abrams CK, Slatin SL, Griffiths G. A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. Cell. 1990 Jun 29;61(7):1277–1287. [PubMed]
  • Pereira ME. A developmentally regulated neuraminidase activity in Trypanosoma cruzi. Science. 1983 Mar 25;219(4591):1444–1446. [PubMed]
  • Harth G, Haidaris CG, So M. Neuraminidase from Trypanosoma cruzi: analysis of enhanced expression of the enzyme in infectious forms. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8320–8324. [PMC free article] [PubMed]
  • Schenkman S, Pontes de Carvalho L, Nussenzweig V. Trypanosoma cruzi trans-sialidase and neuraminidase activities can be mediated by the same enzymes. J Exp Med. 1992 Feb 1;175(2):567–575. [PMC free article] [PubMed]
  • Pereira ME, Hoff R. Heterogeneous distribution of neuraminidase activity in strains and clones of Trypanosoma cruzi and its possible association with parasite myotropism. Mol Biochem Parasitol. 1986 Aug;20(2):183–189. [PubMed]
  • Schenkman S, Jiang MS, Hart GW, Nussenzweig V. A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell. 1991 Jun 28;65(7):1117–1125. [PubMed]
  • Prioli RP, Ordovas JM, Rosenberg I, Schaefer EJ, Pereira ME. Similarity of cruzin, an inhibitor of Trypanosoma cruzi neuraminidase, to high-density lipoprotein. Science. 1987 Dec 4;238(4832):1417–1419. [PubMed]
  • Prioli RP, Rosenberg I, Pereira ME. High- and low-density lipoproteins enhance infection of Trypanosoma cruzi in vitro. Mol Biochem Parasitol. 1990 Jan 15;38(2):191–198. [PubMed]
  • Milder R, Kloetzel J. The development of Trypanosoma cruzi in macrophages in vitro. Interaction with lysosomes and host cell fate. Parasitology. 1980 Feb;80(1):139–145. [PubMed]
  • de Meirelles M de N, de Araujo Jorge TC, de Souza W, Moreira AL, Barbosa HS. Trypanosoma cruzi: phagolysosomal fusion after invasion into non professional phagocytic cells. Cell Struct Funct. 1987 Aug;12(4):387–393. [PubMed]
  • de Carvalho TM, de Souza W. Early events related with the behaviour of Trypanosoma cruzi within an endocytic vacuole in mouse peritoneal macrophages. Cell Struct Funct. 1989 Aug;14(4):383–392. [PubMed]
  • Neiss WF. A coat of glycoconjugates on the inner surface of the lysosomal membrane in the rat kidney. Histochemistry. 1984;80(6):603–608. [PubMed]
  • Kornfeld S, Mellman I. The biogenesis of lysosomes. Annu Rev Cell Biol. 1989;5:483–525. [PubMed]
  • Andrews NW, Colli W. Adhesion and interiorization of Trypanosoma cruzi in mammalian cells. J Protozool. 1982 May;29(2):264–269. [PubMed]
  • Postan M, Dvorak JA, McDaniel JP. Studies of Trypanosoma cruzi clones in inbred mice. I. A comparison of the course of infection of C3H/HEN- mice with two clones isolated from a common source. Am J Trop Med Hyg. 1983 May;32(3):497–506. [PubMed]
  • Mane SM, Marzella L, Bainton DF, Holt VK, Cha Y, Hildreth JE, August JT. Purification and characterization of human lysosomal membrane glycoproteins. Arch Biochem Biophys. 1989 Jan;268(1):360–378. [PubMed]
  • Kawamoto F, Kumada N. Fluorescent probes for detection of protozoan parasites. Parasitol Today. 1987 Sep;3(9):284–286. [PubMed]
  • Cross GA. Glycolipid anchoring of plasma membrane proteins. Annu Rev Cell Biol. 1990;6:1–39. [PubMed]
  • Rosenberg I, Prioli RP, Ortega-Barria E, Pereira ME. Stage-specific phospholipase C-mediated release of Trypanosoma cruzi neuraminidase. Mol Biochem Parasitol. 1991 Jun;46(2):303–305. [PubMed]
  • Deutscher SL, Nuwayhid N, Stanley P, Briles EI, Hirschberg CB. Translocation across Golgi vesicle membranes: a CHO glycosylation mutant deficient in CMP-sialic acid transport. Cell. 1984 Dec;39(2 Pt 1):295–299. [PubMed]
  • Andrews NW, Whitlow MB. Secretion by Trypanosoma cruzi of a hemolysin active at low pH. Mol Biochem Parasitol. 1989 Mar 15;33(3):249–256. [PubMed]
  • Cavallesco R, Pereira ME. Antibody to Trypanosoma cruzi neuraminidase enhances infection in vitro and identifies a subpopulation of trypomastigotes. J Immunol. 1988 Jan 15;140(2):617–625. [PubMed]
  • Souto-Padrón T, Harth G, de Souza W. Immunocytochemical localization of neuraminidase in Trypanosoma cruzi. Infect Immun. 1990 Mar;58(3):586–592. [PMC free article] [PubMed]
  • Prioli RP, Mejia JS, Aji T, Aikawa M, Pereira ME. Trypanosoma cruzi: localization of neuraminidase on the surface of trypomastigotes. Trop Med Parasitol. 1991 Jun;42(2):146–150. [PubMed]
  • Andrews NW, Robbins ES, Ley V, Hong KS, Nussenzweig V. Developmentally regulated, phospholipase C-mediated release of the major surface glycoprotein of amastigotes of Trypanosoma cruzi. J Exp Med. 1988 Feb 1;167(2):300–314. [PMC free article] [PubMed]
  • Takle GB, Cross GA. An 85-kilodalton surface antigen gene family of Trypanosoma cruzi encodes polypeptides homologous to bacterial neuraminidases. Mol Biochem Parasitol. 1991 Oct;48(2):185–198. [PubMed]
  • Pereira ME, Mejia JS, Ortega-Barria E, Matzilevich D, Prioli RP. The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low density lipoprotein receptor, and type III modules of fibronectin. J Exp Med. 1991 Jul 1;174(1):179–191. [PMC free article] [PubMed]
  • Chiarini A, Fiorilli A, Siniscalco C, Tettamanti G, Venerando B. Solubilization of the membrane-bound sialidase from pig brain by treatment with bacterial phosphatidylinositol phospholipase C. J Neurochem. 1990 Nov;55(5):1576–1584. [PubMed]
  • Bülow R, Overath P. Purification and characterization of the membrane-form variant surface glycoprotein hydrolase of Trypanosoma brucei. J Biol Chem. 1986 Sep 5;261(25):11918–11923. [PubMed]
  • Hereld D, Krakow JL, Bangs JD, Hart GW, Englund PT. A phospholipase C from Trypanosoma brucei which selectively cleaves the glycolipid on the variant surface glycoprotein. J Biol Chem. 1986 Oct 15;261(29):13813–13819. [PubMed]
  • Fox JA, Duszenko M, Ferguson MA, Low MG, Cross GA. Purification and characterization of a novel glycan-phosphatidylinositol-specific phospholipase C from Trypanosoma brucei. J Biol Chem. 1986 Nov 25;261(33):15767–15771. [PubMed]
  • Schenkman S, Yoshida N, Cardoso de Almeida ML. Glycophosphatidylinositol-anchored proteins in metacyclic trypomastigotes of Trypanosoma cruzi. Mol Biochem Parasitol. 1988 Jun;29(2-3):141–151. [PubMed]
  • Miller JF, Mekalanos JJ, Falkow S. Coordinate regulation and sensory transduction in the control of bacterial virulence. Science. 1989 Feb 17;243(4893):916–922. [PubMed]
  • Prioli RP, Mejia JS, Pereira ME. Monoclonal antibodies against Trypanosoma cruzi neuraminidase reveal enzyme polymorphism, recognize a subset of trypomastigotes, and enhance infection in vitro. J Immunol. 1990 Jun 1;144(11):4384–4391. [PubMed]
  • Kahn S, Colbert TG, Wallace JC, Hoagland NA, Eisen H. The major 85-kDa surface antigen of the mammalian-stage forms of Trypanosoma cruzi is a family of sialidases. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4481–4485. [PMC free article] [PubMed]
  • Parodi AJ, Pollevick GD, Mautner M, Buschiazzo A, Sanchez DO, Frasch AC. Identification of the gene(s) coding for the trans-sialidase of Trypanosoma cruzi. EMBO J. 1992 May;11(5):1705–1710. [PMC free article] [PubMed]
  • Zingales B, Carniol C, de Lederkremer RM, Colli W. Direct sialic acid transfer from a protein donor to glycolipids of trypomastigote forms of Trypanosoma cruzi. Mol Biochem Parasitol. 1987 Nov;26(1-2):135–144. [PubMed]
  • Pollevick GD, Affranchino JL, Frasch AC, Sánchez DO. The complete sequence of a shed acute-phase antigen of Trypanosoma cruzi. Mol Biochem Parasitol. 1991 Aug;47(2):247–250. [PubMed]
  • Joiner KA. Complement evasion by bacteria and parasites. Annu Rev Microbiol. 1988;42:201–230. [PubMed]
  • Mandrell RE, Lesse AJ, Sugai JV, Shero M, Griffiss JM, Cole JA, Parsons NJ, Smith H, Morse SA, Apicella MA. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med. 1990 May 1;171(5):1649–1664. [PMC free article] [PubMed]
  • Wetzler LM, Barry K, Blake MS, Gotschlich EC. Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect Immun. 1992 Jan;60(1):39–43. [PMC free article] [PubMed]
  • Kipnis TL, David JR, Alper CA, Sher A, da Silva WD. Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. Proc Natl Acad Sci U S A. 1981 Jan;78(1):602–605. [PMC free article] [PubMed]
  • Jiang SB, Ojcius DM, Persechini PM, Young JD. Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins. J Immunol. 1990 Feb 1;144(3):998–1003. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...